Compare IVVD & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IVVD | SMBK |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.7M | 590.0M |
| IPO Year | 2021 | N/A |
| Metric | IVVD | SMBK |
|---|---|---|
| Price | $2.22 | $37.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $8.33 | ★ $38.63 |
| AVG Volume (30 Days) | ★ 11.9M | 58.2K |
| Earning Date | 11-06-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 0.88% |
| EPS Growth | N/A | ★ 41.99 |
| EPS | N/A | ★ 2.74 |
| Revenue | $50,039,000.00 | ★ $188,204,000.00 |
| Revenue This Year | $103.88 | $22.08 |
| Revenue Next Year | $171.40 | $9.89 |
| P/E Ratio | ★ N/A | $13.34 |
| Revenue Growth | ★ 332.71 | 18.22 |
| 52 Week Low | $0.35 | $26.31 |
| 52 Week High | $3.07 | $37.92 |
| Indicator | IVVD | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 64.74 |
| Support Level | $2.09 | $35.22 |
| Resistance Level | $2.60 | $36.95 |
| Average True Range (ATR) | 0.25 | 0.88 |
| MACD | -0.02 | 0.18 |
| Stochastic Oscillator | 41.67 | 96.19 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.